Byondis is an independent Dutch biopharmaceutical company, based in Nijmegen, that focuses on developing innovative medicines against cancer and autoimmune diseases. Our values integrity, authenticity, entrepreneurship, quality and trust are very highly regarded. We are driven
Bring lab-quality diagnostics into the operating theatre. At NBCL (Novel Biomarker Catalyst Lab), were developing Point-of-Care diagnostic solutions that deliver fast, simple, and accurate results exactly where clinicians need them — at the point of decision.